Lantern Pharma rallies $3.7 mln Series A
Lantern Pharma Inc, a clinical-stage biotech company, has raised $3.7 million in Series A financing. The investors included Bios Partners and GPG Ventures.
4 May 2017•1 min read
Lantern Pharma Inc, a clinical-stage biotech company, has raised $3.7 million in Series A financing. The investors included Bios Partners and GPG Ventures.
